No Data
By-Health Co., Ltd. (300146.SZ): has established traditional medicine store and pharmacy channels in several countries in Southeast Asia, as well as cross-border and local e-commerce channels. Currently, the scale is still relatively small.
Grace Bond on November 7th | By-Health Co., Ltd. (300146.SZ) accepted a specific survey on November 6, 2024, on the "company's overseas business layout". The company stated that the current overseas layout is mainly based on the lifespace brand, and has set up traditional pharmacies and beauty channels in several countries in Southeast Asia, as well as cross-border and local e-commerce channels, with the current scale still relatively small.
By-Health Co., Ltd. (300146.SZ): Currently, the inventory levels of the two major core product channels have been controlled within a reasonable range.
Gelonghui November 7th | by-health co., ltd. (300146.SZ) accepted a specific object investigation on November 6, 2024, regarding the progress of the switch of "two core products" and the inventory situation in channels. The company stated that the transition between old and new products has significantly impacted the company's third-quarter performance and is expected to be completed within this year. Currently, the inventory level of the two core products in the channels has been kept within a reasonable range.
Major MSCI adjustment! Brokerage stocks are most favored, 20 companies are being removed.
On November 7th, Beijing time, the international index compiler MSCI announced the results of the November stock index review. Among them, 4 Chinese stocks were newly included in the MSCI China Index, while 20 individual stocks were removed. All changes will take effect after the market closes on November 25, 2024.
Express News | MSCI China Index flagship adjustment: Favoring brokerages, removing stocks such as Anhui Kouzi Distillery.
By-Health Co., Ltd. (300146.SZ): This buyback has not yet been implemented.
Gelonghui November 1st | By-Health Co., Ltd. (300146.SZ) announced that, as of October 31, 2024, the company has not yet implemented this repurchase.
By-Health Co., Ltd. (300146): The adjustment of individual products is nearing completion, and the effects of reform are expected to be realized.
Event: The company released the 2024Q3 quarterly report, with the company's revenue for the first three quarters at 5.734 billion yuan, yoy-26.33%; net income attributable to the parent company at 0.869 billion yuan, yoy-54.31%; non-net profit attributable to the parent company at 8.07 billion yuan.
No Data
No Data